Ranibizumab Injections Reduce Retinal Swelling May 3, 2008
"Some patients stabilize after only a few injections, and some require several injections, but the results are very encouraging," Dr. Peter A. Campochiaro, a professor of ophthalmology and neuroscience, said in a prepared statement ... Information about continued treatment and follow-up of patients was expected to presented Thursday at the Association of Research in Vision and Ophthalmologyannual meeting, in Fort Lauderdale, Fla. (MEDLINEplus)
Revolutionary Eye Procedure Helps Improve Vision in Youth May 2, 2008
by - April 30, 2008 - 0 comments. Doctors at Moorfields Eye Hospital were able to perform a pioneering procedure to improve the eyesight of an 18-year old. (The Money Times)
FDA Panel Urges Stronger Warnings for LASIK Surgery May 2, 2008
The Task Force consists of the FDA, the American Society of Cataract and Refractive Surgery, the American Academy of Ophthalmology, and the U.S. National Eye Institute ... "The FDA has called this a quality-of-life issue, because patients are complaining that their vision isn't sharp, they have poor night vision, some have glare or halos, some complain that their eyes are dry," said Dr. Robert Cykiert, associate professor of ophthalmology at New York University Langone Medical Center ... Those... (MEDLINEplus)
Babies' Development 'Catches Up' After Surgery To Fix Crossed Eyes Apr 22, 2008
21, 2008) Babies with an eye-alignment disorder called infantile esotropia have delays in motor development milestones, but development "catches up" after corrective surgery, reports a study in the April Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus). See also. (Science Daily)
From Boston to Burma, with vision Apr 21, 2008
There were 20 ophthalmology trainees in the operating room observing his three-hour procedure. At the end, the room filled with applause. (Boston Globe)
CCC&TI hosts Lions Vision Van for free screenings Apr 19, 2008
The participants also had the opportunity to meet with Dr. Ron Amaker, from the Wal-Mart Vision Center in Lenoir, or Dr. Brian Adair of Graystone Ophthalmology. Howard said the goal of the program is to give back to the community and to educate the public. (Lenoir News Topic, NC)
Hormone Use Related To Lower Risk Of Macular Degeneration In Postmenopausal Women Apr 18, 2008
3, 2006) Passive smoking almost doubles the risk of the progressively degenerative eye disease, age related macular degeneration, shows research in the British Journal of Ophthalmology. The macula lies at. (Science Daily)
Winchester resident runs Marathon for friend who almost lost vision Apr 18, 2008
MEEI is an international leader in Ophthalmology and Otolaryngology research and a teaching partner of Harvard Medical School. Editor s Note: Vannessa Carrington serves as coordinator of Public Affairs for the Massachusetts Eye and Ear Infirmary, 243 Charles St., Boston. (Winchester Star, MA, MA)
MU researchers find clue to cataract formation Apr 18, 2008
In his study, K. Krishna Sharma, professor of ophthalmology at MU, found that a specific type of protein begins to lose function as the eye ages. As the protein loses function, small peptides, made of 10 to 15 amino acids, start forming and accelerate cataract formation in the eye. (EurekAlert!)
Looking Back... Duke Track & Field Sensation Dave Sime Apr 17, 2008
"He turned me on to ophthalmology. He was a brilliant man. He taught me that eye surgery was more complex and more satisfying than brain surgery.". Sime settled in Miami and became the longtime head of eye surgery at Mercy Hospital. (Theacc.com)
Lexicon's Drug Candidate for Rheumatoid Arthritis, LX2931, Shows Positive Results in Phase 1 Clinical Trial Apr 17, 2008
The company has used its proprietary gene knockout technology to discover more than 100 promising drug targets and create an extensive pipeline of clinical and preclinical programs in the therapeutic areas of cardiology, gastroenterology, immunology and oncology, metabolism, neurology and ophthalmology. To focus its commitment, Lexicon initiated its 10TO10 program to advance 10 new drug candidates into human clinical trials by the end of 2010. (Primezone Releases)
Early Screening Improves Outcomes for Kids With Amblyopia Apr 17, 2008
The study was published in the April issue of the Archives of Ophthalmology. Typical screening for amblyopia consists of visual acuity screening (patients are asked to read letters on a chart) and an examination to detect cataracts, problems with eye alignment and other risk factors for amblyopia, according to background information in the study. (Health-Finder)
Hormone Replacement May Cut Risk for Age-Linked Eye Disease Apr 16, 2008
The study was published in the April issue of the journal Archives of Ophthalmology. HealthDay. (MEDLINEplus)
Cataract Research: Genetic Defect Responsible For Small Eyes And Clouded Lens Discovered Apr 11, 2008
As the scientists in the current issue of the well-known, American journal in the field of ophthalmology, Investigative Ophthalmology & Visual Sciences , report, with the mutant mice, the growth of the fibers that fill up the body of the lenses, is completely blocked ... Investigative Ophthalmology & Visual Science, vol 49, pp 1525-1532. (Science Daily)
Genentech Net Up, Key Drug's Growth Slows Apr 11, 2008
State " Zip: Email: 12 ISSUES FOR $12.00 71% OFF! 24 ISSUES FOR $18.00 79% OFF! 36 ISSUES FOR $24.00 Best Deal! Print Send By Val Brickates Kennedy BOSTON (Dow Jones) -- Genentech Inc. reported a 12% boost in its bottom line late Thursday, largely due to increased sales for its cancer therapies Rituxan, Avastin and Herceptin. Genentech (DNA) posted net income of $790 million for the quarter ended March 31, compared with $706 million for the previous year's quarter. Earnings per share including... (SmartMoney)
Breech delivery is inherited Apr 10, 2008
The analysis, which appears in the April issue of Ophthalmology, is a randomized prospective study of 1,090 people getting cornea transplants ... "Older corneas are just as good for transplantation," said Dr. Edward Holland, a co-author of the study and a professor of ophthalmology at the University of Cincinnati, "and the significance of this study is that surgeons now have scientific evidence that they can use older donors. Potentially, this expands the donor pool considerably.". (International Herald Tribune)
Online cure on cards at MGM Apr 10, 2008
Associate professor of ophthalmology at the Mahatma Gandhi Memorial Medical College Arjun Lal said that the registration process for eye donation had already begun. A large number of steel city residents have come forward for the noble cause, the associate professor said. (Calcutta Telegraph)
Local Eye Doctor Marks 25 Years in Washington Apr 9, 2008
Following graduation, he continued studying internal medicine as an intern at St. John's Mercy Medical Center and later decided to pursue a career in ophthalmology. He performed his residency at Duke University. (Missourian Publishing, MO)
A Flight To Sight Apr 8, 2008
"Then we go into their own hospitals and the local doctors would get similar patients [who required eye surgery], but this time I am on the assistant side of the operating table and they are the primary surgeon," explains Dr. Jack Dodick, professor and chairman of the department of ophthalmology at New York University School of Medicine. "They mimic what I have done. The purpose of the program is to teach and transfer skills." Dodick was on the maiden voyage of the Flying Eye Hospital into China... (New York Post -- Entertainment)
ASCRS to participate in and co-fund study on post-lasik quality of life with US FDA Apr 8, 2008
CHICAGO, ASCRS Symposium and Congress, (April 7, 2008) The American Society of Cataract and Refractive Surgery (ASCRS) today announced that it will participate in a post-LASIK quality of life study with the Joint LASIK Study Task Force, which includes the U.S. Food and Drug Administration (FDA), the National Eye Institute (NEI), ASCRS and the American Academy of Ophthalmology ... Joint LASIK Study Task Force and professor of ophthalmology, Medical University of South Carolina ... The FDA... (EurekAlert!)
Kansas City LASIK Surgeon Dr. Daniel Durrie Joins Elite Circle of Surgeons Listed in Trusted LASIK Surgeons Directory Apr 5, 2008
The most significant professional qualifications that set Dr. Durrie's apart from nearly all other LASIK Surgeons are his experience as a principal investigator for 150 FDA studies for laser manufacturers and pharmaceutical companies, his faculty appointment as a Clinical Associate Professor of Ophthalmology at the University Kansas Medical Center, where he also serves as a Director of Ophthalmic Refractive Surgery Fellowship Program ... Dr. Daniel Durrie, M.D. has been named one of the 50 "Most... (Yahoo News -- Press Releases)
Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems Apr 4, 2008
"Sonomed was well known and respected in the People's Republic of China prior to Medical Device Registration requirements and we look forward to re- introducing our latest line of ophthalmic ultrasound products with similar success," said Barry Durante, President of Sonomed, Inc. "These instruments will provide physicians the opportunity to offer a safe and accurate ultrasound examination to improve their diagnostic capability and patient surgical outcomes." Sonomed, Inc. is a diagnostic... (PR Newswire)
World-Recognized LASIK Expert Dr. James Salz is Listed in Trusted LASIK Surgeons Directory Apr 3, 2008
Among the most significant professional qualifications that set Dr. Salz apart from nearly all other LASIK Surgeons are his experience as a principal investigator for 10 FDA studies for vision correction lasers and lens implants and his academic appointment as a Clinical Professor of Ophthalmology, at USC-Los Angeles County Medical (the Doheny Eye Institute). In addition, Dr. Salz's extensive contributions in refractive care research, including 2 textbooks, 18 book chapters, over 60 articles and... (Yahoo News -- Press Releases)
Age of cornea's donor doesn't affect transplant Apr 2, 2008
A 10-year study funded mainly by the National Eye Institute of the National Institutes of Health and published in the journal Ophthalmology found that corneas from donors older than 65 were as good as those from younger donors ... "There has been a bias of surgeons and patients that older corneas were not as good as younger corneas," said Dr. Jonathan Lass, chairman of the department of ophthalmology and visual sciences at University Hospitals Case Medical Center and Case Western Reserve... (Cleveland.com -- News)
New study raises doubts over favored biotechnology method Apr 2, 2008
"It seems to be working by a completely different mechanism that's unrelated to the underlying premise," said Dr. Jayakrishna Ambati, a professor of ophthalmology at the University of Kentucky and senior author of the study. Ambati and colleagues from several other universities looked in particular at two drugs being developed to treat macular degeneration, a leading cause of blindness in the elderly, one by Opko Health and the other by Allergan. (International Herald Tribune -- Business)
Older corneas transplant as well as young ones Apr 2, 2008
The study was published Tuesday in the journal Ophthalmology. advertisement. (MSNBC -- Health)
Old as good as young for cornea transplants Apr 2, 2008
The study is published Tuesday in the journal Ophthalmology. There was a bias against older tissue, said Dr. Jonathan Lass of University Hospitals Case Medical Center in Cleveland, one of the study's authors. (Globe and Mail)
Transplants Work From Older Eye Donors Apr 2, 2008
The study, published in the journal Ophthalmology, could lead to the expansion of that age limit to 75. Copyright 2008 by. (Click2Houston, TX)
QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension Mar 31, 2008
Glaucoma Glaucoma affects approximately 65 million patients around the world today and is the second leading cause of blindness in the western world, according to the Glaucoma Research Foundation, and WHO. Further, over 50% of glaucoma patients are noncompliant with their eye drop regimen within six months, meaning patients don't refill their prescriptions beyond six months (American Journal of Ophthalmology ... Our research and development efforts are focused on pharmaceutical products in the... (PR Newswire)
NRI scientist contests Nobel winning work Mar 31, 2008
That method was considered a breakthrough because then you could develop drugs to treat any disease as long as you knew what you were targeting,'' said Ambati, India-born professor of ophthalmology at the University of Kentucky ... After completing medical school at the State University of New York and residency in ophthalmology at the University of Rochester, he did a fellowship at Harvard Medical School ... He is currently vice chair of the Department of Ophthalmology and Visual Sciences at... (NDTV.com)
Indian-American red-flags gene cure Mar 30, 2008
"That method was considered a breakthrough because then you could develop drugs to treat any disease as long as you knew what you were targeting," Ambati, an India-born professor of ophthalmology at the University of Kentucky, said in a phone intervie 00004000 w.. Findings of the study have been published in the latest issue of reputed British science journal Nature. (India Times, India -- Health/Science)
Caution Urged Over Revolutionary Gene Treatment Mar 30, 2008
Investigators led by Jayakrishna Ambati, an Indian-born professor of ophthalmology at the University of Kentucky, carried out research on mice using siRNA strands designed to tackle age-related macular degeneration (AMD). AMD is a form of blindness that strikes late in life and affects around 50 million people worldwide. (MedIndia)
Grace under fire Mar 30, 2008
The vitamin analogy is fitting, given that she is a medical doctor and ophthalmology specialist. And she hints of stronger medicine. (The Star Online, Malaysia -- News)
Indian American Challenges Gene Cure Based On Nobel Winning Work Mar 29, 2008
That method was considered a breakthrough because then you could develop drugs to treat any disease as long as you knew what you were targeting,' Ambati, an India-born professor of ophthalmology at the University of Kentucky, told IANS in a phone interview ... After completing medical school at the State University of New York and residency in ophthalmology at the University of Rochester, he did a fellowship at Harvard Medical School ... He is currently vice chair of the Department of... (NEWSPost India)
Gene Silencing Therapies Could Have Harmful Side Effects, Research Suggests Mar 29, 2008
Ambati, professor and vice chair of ophthalmology and visual sciences at the University of Kentucky College of Medicine, and his colleagues have made a critical discovery that challenges the view that siRNA's therapeutic effects are imparted solely through RNA interference. Ambati and collaborators argue that siRNA functions generically rather than specifically, thus the new class of drugs being formulated may actually adversely affect blood vessel growth in a variety of organs. (Science Daily)
Mythbusted: People Who Wear Glasses Aren't Geeks Mar 26, 2008
The research has been published in the March issue of the international eye journal Investigative Ophthalmology & Visual Science. Adapted from materials provided by , via , a service of AAAS.. (Science Daily)
Glasses aren't geeky Mar 26, 2008
"Myopic people do indeed score relatively high on measures of IQ and educational attainment, and intelligent people are commonly stereotyped as introverted, reserved and bookish," they wrote in the journal Investigative Ophthalmology and Visual Science. "By this argument, myopic people may be inaccurately inferred to have these traits because they are accurately seen as intelligent.". (Melbourne Herald Sun)
New treatment for heart failure approved by Health Canada Mar 25, 2008
Novartis Pharmaceuticals Canada Inc. conducts hundreds of clinical trials across the country seeking new treatments for cardiovascular disease, oncology, diabetes, cancer, ophthalmology and organ transplantation. In 2007, the Company invested close to $86 million in research and development. (Canada Newswire)
Trius Raises $30 Million in Series B Financing Mar 24, 2008
Since then, the firm and its Partners have backed entrepreneurs in 100 life science companies working in every area of medicine, including cardiology, cancer, neurology, immune system diseases, ophthalmology, and molecular diagnostics. Since its founding in 1972, KPCB has backed entrepreneurs in over 475 ventures, including AOL, Align Technology, Amazon. (PR Newswire)
Logy and Graph Suffixes Mar 24, 2008
Ophthalmology: branch of medicine concerned with the eye and its diseases. Ornithology: study of birds. (Suite101.com)
Eye Test Peers Into Heat-related Multiple Sclerosis Symptoms Mar 24, 2008
INO can serve as an easy-to-measure "canary in a coal mine," acting as a surrogate for other heat-related symptoms that are harder to measure, such as fatigue, mental confusion or bladder or bowel problems, said Dr. Elliot Frohman, professor of neurology and ophthalmology, director of the Multiple Sclerosis Program and Multiple Sclerosis Clinical Center at UT Southwestern and senior author of the study ... Dr. Elliot Frohman, professor of neurology and ophthalmology, led research demonstrating... (Science Daily)
UH medical students learn their futures Mar 22, 2008
"He is the single best thing that ever happened to the medical school," said David Waters, professor of ophthalmology surgery. Honolulu Star-Bulletin. (Honolulu Star-Bulletin)
Story ideas from the Journal of Biological Chemistry Mar 22, 2008
Corresponding Author: K. Krishna Sharma, Department of Ophthalmology, University of Missouri School of Medicine, Columbia, MO; Phone: 573-882-8478, email. ALS Aggregates are composed of only one protein. (EurekAlert!)
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised) Mar 21, 2008
Co., Ltd. (TSE: 1720) Taisho Pharmaceutical Co., Ltd. (TSE: 4535) Diagnostics Index (HHD) Drop CR Bard, Inc. (NYSE: ) IDEXX Laboratories (Nasdaq: ) Add Bruker Corporation (Nasdaq: ) Halozyme Therapeutic (Nasdaq: ) Emerging Cancer Index (HHJ) Drop Adventrx Pharmaceuticals, Inc. (Amex: ) Keryx Biopharmaceuticals, Inc. (Nasdaq: ) Add Dyanvax Technologies (Nasdaq: ) Synta Pharmaceuticals Corp. (Nasdaq: ) Enabling Technologies Index (HHV) Drop Hillenbrand Industries (NYSE: ) Add Eurand N.V. (Nasdaq:... (PR Newswire)
Implantable Prosthetic Could Restore Sight for the Blind Mar 20, 2008
The project, headed by Mark Humayun, a professor of ophthalmology and biomedical engineering at the Keck School of Medicine of the University of Southern California, involves an implant consisting of 60 electrodes attached to the that conduct information from an external camera to the retina to provide a rudimentary form of sight to patients with the implants. Pezaris has also enlisted the help of Emad Eskandar, a neurosurgeon at MGH who specializes in deep-brain stimulation, which has been used... (Scientific American)
Treating Macular Degeneration Mar 19, 2008
This is a major breakthrough in an area where the advances have been minimal, Randall J. Olson, M.D., director of the Universitys John A. Moran Eye Center and chair of Ophthalmology and Visual Science, was quoted as saying. We are excited about taking this opening and moving the frontier forward with real hope for patients who have but few, often disappointing, options. (Ivanhoe)
New Hope For Regenerating Damaged Human Retina: Sleeping Stem Cells Successfully Awakened Mar 19, 2008
The discovery, published in the March issue of Investigative Ophthalmology and Visual Science (IOVS), offers new hope to victims of diseases that harm the retina, such as macular degeneration and retinitis pigmentosa. See also. (Science Daily)
Carolina Eye Founder Dr. Gale Martin Dies Mar 19, 2008
These procedures were considered the cutting-edge of ophthalmology and obviated the need for a hospital stay, inpatient surgery and the old-fashioned "thick" cataract glasses ... In recent weeks an endowment was established in honor of Martin, by Medical Ministry International (MMI), a nondenominational medical ministry, which provides scholarships to train ophthalmology residents from Third World countries ... Martin's business endeavors went well beyond ophthalmology into varied fields such as... (The Pilot Newspaper)
New clinical leads appointed for NHS IT programme Mar 19, 2008
The new leads practice across a variety of medical fields including ophthalmology, pathology, diabetes, mental health, public health and medication management and will represent their own professional groups ... Mr John Sparrow, a consultant ophthalmologist at the Bristol Eye Hospital since 1992, will become NCL for ophthalmology ... Ms Parul Desai, consultant in ophthalmology and public health at Moorfields Eye Hospital NHS Foundation Trust in London, and honorary senior lecturer at the... (OnMedica)
Study Finds Potential Cause of Age-Related Macular Degeneration Mar 19, 2008
"I think it is very strong science," said Dr. George A. Williams, chairman of the department of ophthalmology at William Beaumont Hospital in Royal Oak, Mich. "It identifies a promising preliminary observation that is going to require a lot more development.". (MEDLINEplus)
Scientists successfully awaken sleeping stem cells Mar 19, 2008
The discovery, published in the March issue of Investigative Ophthalmology and Visual Science (IOVS), offers new hope to victims of diseases that harm the retina, such as macular degeneration and retinitis pigmentosa ... 1 The Schepens Eye Research Institute, Boston, Massachusetts 2 Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 3 Department of Ophthalmology, Asahikawa Medical College, Asahikawa, Japan 4 Department of Genetics, Howard Hughes Medical Institute, Harvard... (EurekAlert!)
Blind vision Mar 18, 2008
"There's a big difference between needing glasses and not being able to see with the glasses," said Dr. John Simon, chief of the ophthalmology department at Albany Medical College. "Second, there is a big difference between being able to see 20/200, which is legally blind by the state's definition, and not being able to see anything at all.". (Albany Times Union)
Drug to cure blindness is 'major breakthrough' Mar 18, 2008
"This work may eventually help those patients, 70 per cent of those diagnosed with 'wet'- AMD, in which the current treatments are still ineffective," says Prof Pete Coffey of the Institute of Ophthalmology, London. Prof Robin Ali, a colleague at the institute, adds: "A treatment based on Robo4 may well prove to have certain advantages over existing treatments based on Lucentis or Avastin - or it might even be used in combination. However, a great deal more research and development is likely to... (Telegraph.co.uk)
Behind the Business Mar 17, 2008
WHY YOUR BUSINESS STANDS OUT: Our business stands out because we offer both optometry and ophthalmology services. This offers the patient full-service eye care. (The Augusta Chronicle)
The Seeing-Eye Gene Mar 17, 2008
In 1993, without much data to support him, Hageman told his theory to an audience at an ophthalmology conference. "They laughed me off the stage," he says. (Forbes)
Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice Mar 17, 2008
D., associate professor of ophthalmology and visual sciences at the University of Utahs John A. Moran Eye Center and an investigator with the Universitys Program in Human Molecular Biology and Genetics ... Randall J. Olson, M.D., director of the Universitys John A. Moran Eye Center and professor and chair of ophthalmology and visual sciences, called Lis finding historic. (EurekAlert!)
Quick Quiz on Eye Health Mar 15, 2008
March 15, 2008 - 8:50 AM Sub-Navigation. A new report shows many of us aren't doing everything we can to save our sight. (WOKR13 Rochester)
Glaucoma associated with increased risk of cardiovascular death in ... Mar 15, 2008
In a population of African origin, persons with diagnosed and treated glaucoma appeared to have an increased risk of death from cardiovascular causes, according to a study by Suh-Yuh Wu, and colleagues in the Departments of Preventive Medicine and Ophthalmology at Stony Brook University, the University of the West Indies, and the Cleveland Clinic Foundation. The study results are published in the March issue of Archives of Ophthalmology. (News-Medical.net)
Glaucoma Raises Risk of Death in Blacks Mar 15, 2008
"Glaucoma is one of the leading causes of visual impairment worldwide," Suh-Yuh Wu and colleagues note in the journal Archives of Ophthalmology ... SOURCE: Archives of Ophthalmology, March 2008. (MEDLINEplus)
Genetic research unveils common origins for distinct clinical diagnoses Mar 10, 2008
D., an associate professor of ophthalmology at the McKusick-Nathans Institute of Genetic Medicine at Hopkins. This is important progress for several reasons. (EurekAlert!)
House to become nonprofit clinic Mar 8, 2008
"It will also have a pediatric physical therapy suite, and we'll have classrooms. Our goal is to have ophthalmology services in the future.". They plan to hire one more physician this summer and eventually will have four doctors when they move in. (The Augusta Chronicle)
Leading cause of blindness creeps up silently, without warning Mar 7, 2008
"It's a silent disease that's asymptomatic in the early stages," said Catherine Birt, glaucoma specialist at Sunnybrook Health Sciences Centre and ophthalmology professor at the University of Toronto. "If caught early, it can be stopped.". (Globe and Mail)
Glaucoma: Reading This Could Save Your Sight Mar 6, 2008
The disease is more frequently seen in people who are 65 and older, said Dr. Anne Louise Coleman, Frances and Ray Stark professor of ophthalmology at the Jules Stein Eye Institute at UCLA. However, it does occur in younger individuals, especially in Hispanics and African-Americans. Eye doctors recommend regular glaucoma screenings beginning at the age of 40, because if detected early enough, the disease can be treated and blindness can be prevented. (Fox News)
National Glaucoma Day, month-long campaign to promote awareness of devastating eye disease Mar 6, 2008
The CNIB Glaucoma Challenge is sponsored by Pfizer Ophthalmology and is part of an award-winning series of online learning tools developed by CNIB and AXS Biomedical Animation Studios Inc. Devastating disease often goes unnoticed, can be treated if caught early Glaucoma leads to damage to the optic nerve and results in vision loss that is essentially progressive and irreversible ... Its purpose is to assure the provision of comprehensive eye care to all Canadians by promoting excellence in... (Canada Newswire)
Newly Developed Anti-malarial Medicine Treats Toxoplasmosis Mar 6, 2008
"JPC-2056 has the potential to replace the standard treatment of pyrimethamine and sulfadiazine," said infectious disease specialist Rima McLeod, professor of ophthalmology at the University of Chicago and senior author of the study. "The drug, taken by mouth, is easily absorbed, bioavailable, and relatively nontoxic. In tissue culture and in mice, it was rapidly effective, markedly reducing numbers of parasites within just a few days.". (Science Daily)